Your browser doesn't support javascript.
loading
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
Tan, Anthony T; Linster, Martin; Tan, Chee Wah; Le Bert, Nina; Chia, Wan Ni; Kunasegaran, Kamini; Zhuang, Yan; Tham, Christine Y L; Chia, Adeline; Smith, Gavin J D; Young, Barnaby; Kalimuddin, Shirin; Low, Jenny G H; Lye, David; Wang, Lin-Fa; Bertoletti, Antonio.
Afiliación
  • Tan AT; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Linster M; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Le Bert N; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Kunasegaran K; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Zhuang Y; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Tham CYL; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Chia A; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Smith GJD; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Young B; National Centre for Infectious Diseases, Singapore, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Cian School of Medicine, Singapore, Singapore.
  • Kalimuddin S; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
  • Low JGH; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore; Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.
  • Lye D; National Centre for Infectious Diseases, Singapore, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore; Lee Kong Cian School of Medicine, Singapore, Singapore; Yong Loo Lin School of Medicine, National University Singapore, Singapore, Singapore.
  • Wang LF; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore.
  • Bertoletti A; Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore; Singapore Immunology Network, A(∗)STAR, Singapore, Singapore. Electronic address: antonio@duke-nus.edu.sg.
Cell Rep ; 34(6): 108728, 2021 02 09.
Article en En | MEDLINE | ID: mdl-33516277

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Interferón gamma / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Cell Rep Año: 2021 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Interferón gamma / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Cell Rep Año: 2021 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Estados Unidos